Go Pro

Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) Now Covered by Analysts at Morgan Stanley

Key Points

  • Morgan Stanley initiated coverage of Vivmark Residential with an “overweight” rating and a $75 price target, implying 10.87% upside from the reported $67.65 share price.
  • Analyst sentiment is broadly positive, with a consensus “Moderate Buy” rating and an average price target of $73.50; recent ratings range from “strong buy” to “hold.”
  • Insiders sold 57,156 shares worth approximately $3.66 million over the past three months, while institutional investors and hedge funds own 92.68% of the stock.
  • Five stocks to consider instead of Vivmark Residential Common Shares of Beneficial Interest.

Stock analysts at Morgan Stanley assumed coverage on shares of Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK - Get Free Report) in a research report issued on Tuesday. The brokerage set an "overweight" rating and a $75.00 price target on the stock. Morgan Stanley's price objective would suggest a potential upside of 10.87% from the stock's current price.

VMRK has been the subject of several other reports. Wells Fargo & Company assumed coverage on Vivmark Residential Common Shares of Beneficial Interest in a report on Friday. They issued an "overweight" rating and a $72.00 price objective for the company. JPMorgan Chase & Co. assumed coverage on Vivmark Residential Common Shares of Beneficial Interest in a research note on Monday. They set a "neutral" rating and a $73.00 price target for the company. Weiss Ratings started coverage on Vivmark Residential Common Shares of Beneficial Interest in a research note on Wednesday, August 19th. They issued a "hold (c)" rating on the stock. Cantor Fitzgerald reissued a "neutral" rating and set a $70.00 target price on shares of Vivmark Residential Common Shares of Beneficial Interest in a research report on Tuesday. Finally, Evercore initiated coverage on Vivmark Residential Common Shares of Beneficial Interest in a research note on Tuesday, August 18th. They set an "in-line" rating and a $72.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $73.50.

Get Our Latest Report on Vivmark Residential Common Shares of Beneficial Interest

Vivmark Residential Common Shares of Beneficial Interest Stock Performance

Shares of NYSE VMRK traded down $0.49 during trading hours on Tuesday, reaching $67.65. 742,342 shares of the stock traded hands, compared to its average volume of 3,050,429. The stock has a market cap of $25.36 billion, a price-to-earnings ratio of 29.37, a P/E/G ratio of 5.62 and a beta of 0.73. Vivmark Residential Common Shares of Beneficial Interest has a 52-week low of $57.57 and a 52-week high of $71.50. The company has a current ratio of 0.19, a quick ratio of 0.19 and a debt-to-equity ratio of 0.77.

Insider Activity

In other Vivmark Residential Common Shares of Beneficial Interest news, Director Christopher B. Howard sold 8,486 shares of the firm's stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $64.00, for a total value of $543,104.00. Following the sale, the director directly owned 12,730 shares of the company's stock, valued at approximately $814,720. This trade represents a 40.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Edward M. Schulman sold 16,595 shares of the business's stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $64.29, for a total value of $1,066,892.55. Following the completion of the sale, the executive vice president owned 48,776 shares of the company's stock, valued at $3,135,809.04. This trade represents a 25.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 57,156 shares of company stock worth $3,662,055. 1.20% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Vivmark Residential Common Shares of Beneficial Interest

An institutional investor recently bought a new position in Vivmark Residential Common Shares of Beneficial Interest stock. Syon Capital LLC acquired a new stake in Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 5,206 shares of the company's stock, valued at approximately $354,000. 92.68% of the stock is currently owned by institutional investors and hedge funds.

Vivmark Residential Common Shares of Beneficial Interest Company Profile

(Get Free Report)

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, DC, Seattle, San Francisco, Southern California and Denver.

Featured Articles

Analyst Recommendations for Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Vivmark Residential Common Shares of Beneficial Interest Right Now?

Before you consider Vivmark Residential Common Shares of Beneficial Interest, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivmark Residential Common Shares of Beneficial Interest wasn't on the list.

While Vivmark Residential Common Shares of Beneficial Interest currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines